|
Federal
Register Notices > Notices of
Registration - 2007
>
Cerilliant Corporation
FR Doc E7-23508 [Federal Register: December 4, 2007 (Volume 72, Number 232)]
[Notices] [Page 68193-68195] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04de07-99]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated August 16, 2007, and published in the Federal Register on
August 28, 2007, (72 FR 49315-49316), Cerilliant Corporation, 811 Paloma Drive,
Suite A, Round Rock, Texas 78664, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
N,N-Dimethylamphetamine (1480)
|
I
|
|
Aminorex (1585)
|
I
|
|
4-Methylaminorex (cis isomer) (1590)
|
I
|
|
Gamma-Hydroxybutyric acid (2010)
|
I
|
|
Methaqualone (2565)
|
I
|
|
Alpha-Ethyltryptamine (7249)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
|
3,4,5-Trimethoxyamphetamine (7390)
|
I
|
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
2,5-Dimethoxy-4-ethylamphetamine (7399)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
5-Methoxy-3,4-methylenedioxyamphetamine (7401)
|
I
|
|
N-Hydroxy-3,4-methylendioxyamphetamine (7402)
|
I
|
|
3,4-Methylendioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Alpha-methyltryptamine (7432)
|
I
|
|
Bufotenine (7433)
|
I
|
|
Diethyltryptamine (7434)
|
I
|
|
Dimethyltryptamine (7435)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
Acetyldihydrocodeine (9051)
|
I
|
|
Benzylmorphine (9052)
|
I
|
|
Codeine-N-oxide (9053)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Heroin (9200)
|
I
|
|
Hydromorphinol (9301)
|
I
|
|
Methyldihydromorphine (9304)
|
I
|
|
Morphine-N-oxide (9307)
|
I
|
|
Normorphine (9313)
|
I
|
|
Pholcodine (9314)
|
I
|
|
Acetylmethadol (9601)
|
I
|
|
Allylprodine (9602)
|
I
|
|
Alphacetylmethadol except levo-alphacetylmethadol (9603)
|
I
|
|
Alphameprodine (9604)
|
I
|
|
Alphamethadol (9605)
|
I
|
|
Betacetylmethadol (9607)
|
I
|
|
Betameprodine (9608)
|
I
|
|
Betamethadol (9609)
|
I
|
|
Betaprodine (9611)
|
I
|
|
Hydroxypethidine (9627)
|
I
|
|
Noracymethadol (9633)
|
I
|
|
Norlevorphanol (9634)
|
I
|
|
Normethadone (9635)
|
I
|
|
Trimeperidine (9646)
|
I
|
|
Phenomorphan (9647)
|
I
|
|
Para-Fluorofentanyl (9812)
|
I
|
|
3-Methylfentanyl (9813)
|
I
|
|
Alpha-Methylfentanyl (9814)
|
I
|
|
Acetyl-alpha-methylfentanyl (9815)
|
I
|
|
Beta-hydroxyfentanyl (9830)
|
I
|
|
Beta-hydroxy-3-methylfentanyl (9831)
|
I
|
|
Alpha-Methylthiofentanyl (9832)
|
I
|
|
3-Methylthiofentanyl (9833)
|
I
|
|
Thiofentanyl (9835)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Phenmetrazine (1631)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Ambobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
Glutethimide (2550)
|
II
|
|
Nabilone (7379)
|
II
|
|
1-Phenylcyclohexylamine (7460)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
1-Piperidinocyclohexanecarbonitrile (8603)
|
II
|
|
Alphaprodine (9010)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Diphenoxylate (9170)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Levomethorphan (9210)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Isomethadone (9226)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone intermediate (9254)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage forms)(9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Noroxymorphone (9668)
|
II
|
|
Racemethorphan (9732)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Sufentanil (9740)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture small quantities of the listed controlled
substances to make reference standards which will be distributed to their
customers.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Cerilliant
Corporation to manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated
Cerilliant Corporation to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and testing
of the company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's background
and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR
1301.33, the above named company is granted registration as a bulk manufacturer
of the basic classes of controlled substances listed.
Dated: November 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E7-23508 Filed 12-3-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
